RIBER completes phase I of ROSIE with a partnership agreement signed with NQCP, a leading research center in Denmark Bezons (France), June 17, 2025 – 6:00pm (CET) – RIBER, the global leader in Molecular Beam Epitaxy (MBE) equipment for the semiconductor industry, announces the signing of a three-year collaborative partnership with the Novo Nordisk Foundation Quantum Computing Programme (NQCP), a world-class research center based in Denmark. A strategic partnership to qualify the ROSIE process, the first ...

Callum Ilott Helmet Callum Ilott with New Lottery.com branded helmet Louis Foster Posed Gateway Louis Foster with his Sports.com branded car Seb Murrary Car BAckground Seb Murrary getting into the zone with Lottery.com branded car in the background MADISON, Ill., June 16, 2025 (GLOBE NEWSWIRE) -- It was a weekend of high drama, fast pace, and standout performances across both the NTT INDYCAR SERIES and INDY NXT by Firestone, as Sports.com and Lottery.com drivers Callum Ilott, Louis Foster and Se ...

RW Group Left to Right: Laura O’Connell, Graeme Grew, Jordan Dolishka Racing Women Hat Racing Woman Hat FORT WORTH, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- Lottery.com Inc. (Nasdaq: LTRY, LTRYW) (“Lottery.com” or “the Company”) and Sports.com announced a sponsorship agreement with Racing Women LLC, the movement pioneering access and opportunity for women in motorsports and STEM programs worldwide. With 4,500 women from more than 70 countries already engaged in its global community, Racing Women, le ...

Market and Growth - The AI photonics market is experiencing rapid growth, with a Compound Annual Growth Rate (CAGR) exceeding 25%[22] - The AI photonics market is expected to grow from $10 billion in 2024 to over $30 billion in 2029[22] - Lumentum aims to achieve over $3 billion in annual revenue, driven by AI photonics leadership, with an operating margin exceeding 20%[31] Technology and Innovation - InP (Indium Phosphide) is becoming increasingly important for higher data rate lane speeds, improving power-per-bit efficiency[40] - Lumentum's InP solutions are projected to constitute 61% of lanes in 2029, compared to 81% in 2024, while VCSEL solutions will constitute 39% of lanes in 2029, compared to 19% in 2024[40] - Differential-drive EML (Electro-absorption Modulated Laser) technology can reduce power consumption by 10-15% at 200G lane speeds compared to CW-SiPho solutions[51] - Advanced InP laser roadmap offers multiple pathways to reduce power consumption, with potential power reductions of approximately 40% for LPO transceivers and 45% for CPO pluggable solutions[56] Optical Switching (OCS) - Optical switching can achieve over 65% power reduction in 100K-scale GPU deployments[73] - The market opportunity for optical circuit switching (OCS) is projected to exceed $1.5 billion by 2029[73] Financial Targets - Lumentum is targeting an operating margin exceeding 20% at >$3 billion annual revenue[111] - Lumentum's FY25 consensus operating margin is 8.4%, with a target to expand this by over 1,100 bps (basis points) primarily driven by Cloud & AI[105]

12 June 2025 | 9:11PM HKT GC Tech: Focuslight (688167.SS): Laser and Optics components, rising demand from local SPE and data center We talked to Focuslight (688167.SS, not covered) management recently. Key takeaways 1. Key growth drivers in 2025: Management views laser and optical products for (1) pan-semiconductor, (2) optical communication, (3) AR/ VR market as key drivers this year, and expects to see double digit revenues YoY growth in 2025E. The company has global customer base and is shifting some of ...

The Iron Dames were born in 2018. It's an it's an all female project that is supporting women in motorsport, not only as drivers, but as engineers, mechanics on the marketing side because the sport is it's huge and it can it needs people like like women as well. And uh the project is special because we are an all female lineup sharing a car, three three women racing against all the others.In the end of the day, like we always say, we uh when we put the helmets on, we are race drivers like anybody else. Um, ...

WOBURN, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company focused on the development and commercialization of photodynamic therapy (PDT), confirms a disclosure by the Management Board of Biofrontera AG on June 10, 2025, according to which the two companies are in negotiations regarding a possible combination of the two companies or an adjustment of the license and supply agreement between them. The latter could result in the transfer of certain rights and ...

My name is Sarmad and today I want to talk about building effective agents with model context protocol or MCP. So a lot has changed in the last year. Um especially as far as agent development is concerned.I think 2025 is the year of agents and uh things like MCP make agent design simpler and more robust than ever before. So I want to talk about what the agent tech stack looks like in 2025. The second thing is a lot of uh MCP servers today are just you know onetoone mappings of existing REST API uh uh servic ...

Zimmer Biomet (ZBH) FY Conference June 09, 2025 09:20 AM ET Speaker0 Okay. Good morning, everyone. We'll go ahead and get started here. Very pleased to welcome Ivan Tornos, Chairman and CEO of Zimmer Biomet and Sukhi Upade, Executive Vice President and CFO. As with all of these sessions, if you have a question, feel free to raise your hand. I certainly have have plenty to keep us to keep us going here, but obviously, we wanna keep this as interactive as possible. So why don't we start with with a topic that ...

PRINCETON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today spotlights the efforts of Ellen Kim, M.D., Lead Principal Investigator for the Company’s Phase 3 FLASH (1 and 2) studies in early stage cutaneous T-cell lymphoma (CTCL), in advancing HyBryte™ (synthetic hypericin) as a potential new th ...